|
Volumn 10, Issue 1, 2004, Pages 26-27
|
Androgen receptor outwits prostate cancer drugs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANDROGEN RECEPTOR;
ANTIANDROGEN;
ANTINEOPLASTIC AGENT;
GONADORELIN DERIVATIVE;
PROSTATE SPECIFIC ANTIGEN;
CANCER CELL;
CANCER HORMONE THERAPY;
CANCER MORTALITY;
CARCINOGENESIS;
CELL PROLIFERATION;
CELL SURVIVAL;
DIMERIZATION;
GENE EXPRESSION;
HORMONE ACTION;
HUMAN;
LIGAND BINDING;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROTEIN EXPRESSION;
RECEPTOR BINDING;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
UNITED STATES;
DNA MICROARRAY;
DRUG RESISTANCE;
GENETICS;
MALE;
NOTE;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
PROSTATE TUMOR;
ANTINEOPLASTIC AGENTS;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
MALE;
OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;
PROSTATIC NEOPLASMS;
RECEPTORS, ANDROGEN;
|
EID: 1842612442
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0104-26 Document Type: Short Survey |
Times cited : (142)
|
References (19)
|